Agenus (AGEN)
(Real Time Quote from BATS)
$7.94 USD
+0.52 (7.01%)
Updated Apr 25, 2024 12:06 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Income Statements
Fiscal Year end for Agenus Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 156 | 98 | 296 | 88 | 150 |
Cost Of Goods | 3 | 11 | 3 | 2 | 0 |
Gross Profit | 153 | 87 | 292 | 86 | 150 |
Selling & Adminstrative & Depr. & Amort Expenses | 313 | 267 | 266 | 203 | 220 |
Income After Depreciation & Amortization | -160 | -179 | 26 | -117 | -70 |
Non-Operating Income | 0 | 11 | 11 | -5 | 0 |
Interest Expense | 98 | 62 | 66 | 61 | 41 |
Pretax Income | -257 | -231 | -29 | -183 | -112 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -12 | -11 | -5 | -2 | -4 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -257 | -231 | -29 | -183 | -112 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -246 | -220 | -24 | -181 | -108 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -146 | -172 | 33 | -110 | -63 |
Depreciation & Amortization (Cash Flow) | 14 | 7 | 7 | 7 | 7 |
Income After Depreciation & Amortization | -160 | -179 | 26 | -117 | -70 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 18.66 | 14.79 | 13.06 | 8.71 | 6.97 |
Diluted EPS Before Non-Recurring Items | -13.80 | -15.60 | -2.80 | -21.00 | -16.00 |
Diluted Net EPS (GAAP) | -13.80 | -15.60 | -2.20 | -21.00 | -16.00 |
Fiscal Year end for Agenus Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 83.80 | 24.31 | 25.30 | 22.90 |
Cost Of Goods | NA | 0.26 | 0.30 | 0.25 | 2.29 |
Gross Profit | NA | 83.54 | 24.01 | 25.04 | 20.61 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 87.74 | 70.35 | 79.71 | 74.95 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -4.20 | -46.34 | -54.67 | -54.34 |
Non-Operating Income | NA | -0.20 | 0.44 | -0.24 | 0.04 |
Interest Expense | NA | 44.18 | 18.63 | 18.52 | 16.59 |
Pretax Income | NA | -48.58 | -64.53 | -73.43 | -70.89 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -2.29 | -2.33 | -4.41 | -2.64 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -48.58 | -64.53 | -73.43 | -70.89 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -46.29 | -62.20 | -69.02 | -68.25 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 18.69 | 20.17 | 18.36 | 16.11 |
Diluted EPS Before Non-Recurring Items | NA | -2.60 | -3.20 | -4.00 | -4.40 |
Diluted Net EPS (GAAP) | NA | -2.20 | -3.20 | -4.00 | -4.40 |